Drugs used to treat hypertension Desirable to know/learn • Classification of Antihypertensive • Antihypertensive mechanisms: Diuretics, ACE inhibitors, ARBs, Beta-blockers, alpha-blockers, CCBs, Vasodilators and central sympatholytics • Present status of above mentioned group of Drugs • Common Adverse effects of above groups of Drugs • Pharmacotherapy of Hypertension • Pharmacotherapy of hypertensive emergencies • Preparation and dosage of commonly used drugs of above mentioned groups Introduction Hypertension > 140 mmHg > 90 mmHg **************************************************** Systolic Blood Pressure (SBP) Diastolic Blood Pressure (DBP) Types of Hypertension Essential Secondary A disorder of unknown origin affecting the Blood Pressure regulating mechanisms Secondary to other disease processes **************************************************** Environmental Factors Stress Na+ Intake Obesity Smoking Hypertension - risk factor for: ischemic heart disease, stroke, renal failure and heart failure Classification of BP Category • Normal • High normal Hypertension • Stage 1 • Stage 2 • Stage 3 • Stage 4 Systolic <130 <139 Diastolic <85 <89 140-159 160-179 180-209 >210 90-99 100-109 110-119 >120 Hypertension Essential (primary) Secondary - most (90-95 %) patients with persistent arterial hypertension - genesis of hypertension unknown - predisposing factors: - is secondary to some distinct disease: susceptive (obesity, stress, salt intake, lack of Mg2+, K+, Ca2+, ethanol dose, smoking) non-susceptive (positive family history, insulin resistance, age, sex, defect of local vasomotoric regualtion) Renal + renovascular disease (artery stenosis) Hormonal defects (Cushing´s syndrome, phaeochromocytoma) Mechanical defect (coarctation of aorta) Hypertension in pregnancy Drug-induced hypertension (sympatomimetics, glucocorticoids) Neurologic disease Antihypertensive Drugs 1. Diuretics: • Thiazides: Hydrochlorothiazide, chlorthalidone • High ceiling: Furosemide • K+ sparing: Spironolactone, triamterene and amiloride MOA: Acts on Kidneys to increase excretion of Na and H2O – decrease in blood volume – decreased BP 2. Angiotensin-converting Enzyme (ACE) inhibitors: • Captopril, lisinopril., enalapril, ramipril and fosinopril MOA: Inhibit synthesis of Angiotensin II – decrease in peripheral resistance and blood volume 3. Angiotensin (AT2 R) blockers: • Losartan, candesartan, valsartan and telmisartan MOA: Blocks binding of Angiotensin II to its receptors Antihypertensive Drugs 4. Centrally acting: • Clonidine, methyldopa, Moxonidine MOA: Act on central α2A receptors to decrease sympathetic outflow – fall in BP 5. ß-adrenergic blockers: • Non selective: Propranolol (others: nadolol, timolol, pindolol, labetolol) • Cardioselective: Metoprolol (others: atenolol, esmolol, betaxolol) MOA: Bind to beta adrenergic receptors and blocks the activity • ß and α – adrenergic blockers: • Labetolol and carvedilol 6. α – adrenergic blockers: • Prazosin, terazosin, doxazosin, (phenoxybenzamine and phentolamine) MOA: Blocking of alpha adrenergic receptors in smooth muscles vasodilatation Antihypertensive Drugs – 7. Calcium Channel Blockers (CCB): • Verapamil, diltiazem, nifedipine, felodipine, amlodipine, nimodipine etc. MOA: Blocks influx of Ca++ in smooth muscle cells – relaxation of SMCs – decrease BP 8. K+ Channel activators: • Diazoxide, minoxidil, pinacidil and nicorandil MOA: Leaking of K+ due to opening – hyper polarization of SMCs – relaxation of SMCs 9. Vasodilators: • Arteriolar – Hydralazine (also CCBs and K+ channel activators) • Arterio-venular: Sodium Nitroprusside ACE inhibitors •Captopril, lisinopril., enalapril, ramipril and fosinopril etc. ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACEI) Captopril, enalapril, quinapril, lisinopril, perindopril, ramipril Clinical Indications - hypertension where thiazide diuretics and beta-blockers are contraindicated - useful in hypertensive patients with heart failure (beneficial effect) - can limit the size of myocardial infarction - diabetic nephropathy ACE inhibitors Drug Duration of effect (hours) Short-acting: captopril Medially-acting: enalapril 6-8 12 quinapril perindopril Long-acting: lisinopril spirapril ramipril 24 AT2 RECEPTOR BLOCKERS losartan, valosartan, irbesartan - the receptor blockers - competitively inhibit angiotensin II at its AT1 receptor site most of the effects of angiotensin II - including vasoconstriction and aldosterone release - are mediated by the AT1 receptor (angiotensin II synthesis in tissue is not completely dependent only on renin release, e.g. in heart, but could be promote by serinprotease - stronger influence on the myocard remodelling) Thiazides — particularly indicated for hypertension in the elderly; a contraindication is gout; Beta-blockers — indications include myocardial infarction, angina; compelling contra-indications include asthma, heart block; ACE inhibitors — indications include heart failure, left ventricular dysfunction and diabetic nephropathy; contra-indications include renovascular disease and pregnancy; when thiazides and beta-blockers are contra-indicated, not tolerated, or fail to control blood pressure Angiotensin-II receptor antagonists are alternatives for those who cannot tolerate ACE inhibitors because of persistent dry cough, but they have the same contra-indications as ACE inhibitors; Calcium-channel blockers. a) Dihydropyridine calcium-channel blockers are valuable in isolated systolic hypertension in the elderly when a low-dose thiazide is contra-indicated or not tolerated. b) ‘Rate-limiting’ calcium-channel blockers (e.g. diltiazem, verapamil) may be valuable in angina; contraindications include heart failure and heart block; Alpha-blockers — a possible indication is prostatism; a contra-indication is urinary incontinence. *BNF 51th edition, 2006 A single antihypertensive drug is often not adequate and other antihypertensive drugs are usually added in a step-wise manner until control is achieved. Unless it is necessary to lower the blood pressure urgently, an interval of at least 4 weeks should be allowed to determine response. Where two antihypertensive drugs are needed → 1. an ACE inhibitor or an angiotensin-II receptor antagonist or a beta-blocker may be combined with → 2. either a thiazide or a calcium-channel blocker. If control is inadequate with 2 drugs, a thiazide and a calcium-channel blocker may be added. In patients at high risk of diabetes it is best to avoid a combination of a beta-blocker and a thiazide. In patients with primary hyperaldosteronism, spironolactone is effective. *BNF 51th edition, 2006 Treatment of Hypertension – General principles • Stage I: • Start with a single most appropriate drug with a low dose. Preferably start with Thiazides. Others like beta-blockers, CCBs, ARBs and ACE inhibitors may also be considered. CCB – in case of elderly and stroke prevention. If required increase the dose moderately • Partial response or no response – add from another group of drug, but remember it should be a low dose combination • If not controlled – change to another low dose combination • In case of side effects lower the dose or substitute with other group • Stage 2: Start with 2 drug combination – one should be diuretic Treatment of Hypertension – combination therapy • In clinical practice a large number of patients require combination therapy – the combination should be rational and from different patterns of haemodynamic effects • Sympathetic inhibitors (not beta-blockers) and vasodilators + diuretics • Diuretics, CCBs, ACE inhibitors and vasodilators + beta blockers (blocks renin release) • Hydralazine and CCBs + beta-blockers (tachycardia countered) • ACE inhibitors + diuretics • 3 (three) Drug combinations: CCB+ACE/ARB+diuretic; CCB+Beta blocker+ diuretic; ACEI/ARB+ beta blocker+diuretic Treatment of Hypertension. • Never combine: • Alpha or beta blocker and clonidine - antagonism • Nifedepine and diuretic synergism • Hydralazine with DHP or prazosin – same type of action • Diltiazem and verapamil with beta blocker – bradycardia • Methyldopa and clonidine • Hypertension and pregnancy: • No drug is safe in pregnancy • Avoid diuretics, propranolol, ACE inhibitors, Sodium nitroprusside etc • Safer drugs: Hydralazine, Methyldopa, cardioselective beta blockers and prazosin Hypertension in pregnancy Methyldopa is safe in pregnancy. Beta-blockers are effective and safe in the third trimester. Modifiedrelease preparations of nifedipine [unlicensed] are also used for hypertension in pregnancy. Intravenous administration of labetalol can be used to control hypertensive crises; alternatively, hydralazine may be used by the intravenous route. Magnesium sulphate in pre-eclampsia and eclampsia Hypertensive Emergencies • Cerebrovascular accident or head injury with high BP • Left ventricular failure with pulmonary edema due to hypertension • Hypertensive encephalopathy • Angina or MI with raised BP • Acute renal failure with high BP • Eclampsia • Pheochromocytoma, cheese reaction and clonidine withdrawal • Drugs: • Sodium Nitroprusside (20-300 mcg/min) – dose titration and monitoring • GTN (5-20 mcg/min) – cardiac surgery, LVF, MI and angina • Esmolol (0.5 mg/kg bolus) and 50-200mcg/kg/min - useful in reducing cardiac work • Phentolamine – pheochromocytoma, cheese reaction and clonidine withdrawal (5-10 mg IV)